• Home
  • News
  • Learn
    • What is PBM?
      • History of PBM
    • Patient Advice
      • Importance of Blood
      • What Your Doctor Should Tell You
      • Doctor/Patient Relationship
      • 3 Simple Questions To Ask Your Doctor
    • PBM for Health Professionals
      • How IFPBM Can Support You
      • Learn About PBM
      • Research
  • Resources
    • Articles
    • Videos
    • Textbooks
    • Guidelines
    • Conferences
    • Speakers
    • Links
  • About
    • Board of Trustees
      • Prof. Dr. Hans Gombotz
    • Scientific Associates
    • Contact Us
    • Network
    • Support / Collaborate
    • Donate
  • English
    • 简体中文 (Chinese (Simplified))
    • Português (Portuguese (Portugal))
    • Español (Spanish)
  • Home
  • News
  • Learn
    • What is PBM?
      • History of PBM
    • Patient Advice
      • Importance of Blood
      • What Your Doctor Should Tell You
      • Doctor/Patient Relationship
      • 3 Simple Questions To Ask Your Doctor
    • PBM for Health Professionals
      • How IFPBM Can Support You
      • Learn About PBM
      • Research
  • Resources
    • Articles
    • Videos
    • Textbooks
    • Guidelines
    • Conferences
    • Speakers
    • Links
  • About
    • Board of Trustees
      • Prof. Dr. Hans Gombotz
    • Scientific Associates
    • Contact Us
    • Network
    • Support / Collaborate
    • Donate
  • English
    • 简体中文 (Chinese (Simplified))
    • Português (Portuguese (Portugal))
    • Español (Spanish)
Log in

International Foundation for Patient Blood Management (IFPBM)

Hemopoiesis

  • Anemia evaluation
  • Erythropoiesis-stimulating agents (ESAs)
    • Medical application
    • Surgical application
  • Hematinics
  • Iron
  • Other
  • Platelet stimulants

Medical application

Title

Date Published

Managing erythropoietin hyporesponsiveness.

March 31, 2006

Phase III Study of Two Different Dosing Schedules of Erythropoietin in Anemic Patients With Cancer.

March 1, 2006

Anemia in patients with midgut carcinoid, treated with alpha interferon: effects by erythropoietin treatment on the perceived quality of life.

March 1, 2006

Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis.

February 23, 2006

Epoetin beta in oncology: examining the current evidence.

February 1, 2006

Epoetin beta (NeoRecormon) therapy in patients with solid tumours receiving platinum and non-platinum chemotherapy: a meta-analysis.

January 31, 2006

The role of erythropoietin therapy in the critically ill.

January 1, 2006

Treatment of Chemotherapy-Induced Anemia in Breast Cancer: Results of a Randomized Controlled Trial of Darbepoetin Alfa 200 mug Every 2 Weeks Versus Epoetin Alfa 40,000 U Weekly.

December 1, 2005

Recombinant human erythropoietin in a triplet pregnancy: a case report.

November 1, 2005

Erythropoietic agents in anaemic patients with cancer: a retrospective observational survey of epoetin alpha, epoetin beta and darbepoetin alpha use in routine clinical practice.

October 1, 2005

Recombinant human erythropoietin in the treatment of nonrenal anemia.

August 3, 2005

« Previous 1 … 5 6 7

IFPBM is funded by your subscriptions & donations

Subscribe

Donate

Privacy Policy

Cookie Policy

IFPBM Terms & Conditions

© The International Foundation for Patient Blood Management
Images Copyright: 123RF Stock Photo
Custom Websites for Non-Profit Health Providers

  • Twitter
  • Instagram
  • Facebook
  • LinkedIn